| Literature DB >> 24400676 |
Viola Voncken-Brewster1, Huibert Tange, Albine Moser, Zsolt Nagykaldi, Hein de Vries, Trudy van der Weijden.
Abstract
BACKGROUND: Changes in reimbursement have been compelling for Dutch primary care practices to apply a disease management approach for patients with chronic obstructive pulmonary disease (COPD). This approach includes individual patient consultations with a practice nurse, who coaches patients in COPD management. The aim of this study was to gauge the feasibility of adding a web-based patient self-management support application, by assessing patients' self-management, patients' health status, the impact on the organization of care, and the level of application use and appreciation.Entities:
Mesh:
Year: 2014 PMID: 24400676 PMCID: PMC3907149 DOI: 10.1186/1471-2296-15-4
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Baseline characteristics of patients
| Median = 56 (39 to 82) | |
| | |
| Male | 8 (72.7%) |
| Female | 3 (27.3%) |
| | |
| Stage 0 | 1 (9.1%) |
| Stage 1 | 3 (27.3%) |
| Stage 2 | 7 (63.6%) |
| Median = 64.3 (45.2 to 74.0) | |
| Median = 26.2 (17.3 to 31.4) | |
| | |
| In a relationship | 1 (9.1%) |
| Married | 9 (81.8%) |
| Divorced | 1 (9.1) |
| | |
| Dutch | 11 (100%) |
| | |
| Primary school/basic vocational school | 3 (27.3%) |
| Secondary vocational school/high school degree | 7 (63.6%) |
| Higher professional degree/university degree | 1 (9.1%) |
| | |
| Employed | 8 (72.7%) |
| Not employed | 3 (27.3%) |
Results of patients’ self-management and health status of complete cases
| | | | |
| cigarettes/day (n = 4) | 20.0 (10.0 to 40.0) | 15.0 (10.0 to 40.0) | −2.5 (0.0 to 5.0) |
| | | | |
| days/week (n = 8) | 5.0 (0.0 to 7.0) | 5.0 (0.0 to 7.0) | 0.0 (−5.0 to 5.0) |
| SQUASH (minutes/day) (n = 4) | 336.0 (54.0 to 564.0) | 347.5 (132.0 to 540.0) | −39.0 (−66.0 to 161.0) |
| | | | |
| Poor/moderate/good (scoring 1 to 3) (n = 8) | 3.0 (2.0 to 3.0) | 3.0 (2.0 to 3.0) | 0.0 (−1.0 to 1.0) |
| MARS5 (scoring: 0 to 25) (n = 4) | 23.5 (23.0 to 24.0) | 23.0 (20.0 to 25.0) | −0.5 (−4.0 to 2.0) |
| | | | |
| FEV1% post-PB (n = 8) | 66.2 (45.2 to 73.6) | 63.1 (46.3 to 72.4) | 0,4 (−7.4 to 4.3) |
| MRC (scoring: 1 to 5) (n = 5) | 1.0 (1.0 to 2.0) | 1.0 (1.0 to 1.0) | 0.0 (−1.0 to 0.0) |
| CCQ (scoring: 0 to 6) (n = 4) | 1.0 (0.5 to 1.6) | 0.8 (0.1 to 2.4) | −0.2 (−0.4 to 0.8) |
Figure 1Frequency of application use of 11 patients during the intervention period.